FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michele Caraglia

Research Profile

Chemicals & Drugs

Procedures

Antineoplastic Combined Chemotherapy Protocols

Anatomy

Physiology

Disorders

Co-author Network

Publications

TOP 3
Alessandra F Perna; Immacolata Sepe; Silvia Zappavigna; Diana Lanza; Giovambattista Capasso; Rosanna Capasso; Michele Caraglia; Diego Ingrosso
Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation.
Alessandra Dicitore; Leo J Hofland; Daniela Mari; Luca Persani; Michele Caraglia; Annamaria Colao; Silvia Zappavigna; Giovanni Vitale
Combined Treatment with PPAR-γ Agonists in Pancreatic Cancer: A Glimmer of Hope for Cancer Therapy?
Giuseppe Di Lorenzo; Rossella Di Trolio; Paolo A Ascierto; carlo buonerba; Michele Caraglia; Renato De Domenico; Sabino De Placido; Gabriella Gaudioso; Vincenzo Gigantino; Sisto Perdonà; giuseppe quarto; Renato Franco
EGFR mutational status in penile cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michele Caraglia (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Alessandra F Perna; Immacolata Sepe; Silvia Zappavigna; Diana Lanza; Giovambattista Capasso; Rosanna Capasso; Michele Caraglia; Diego Ingrosso
Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation.
Journal of cellular biochemistry 2013;114(7):1536-48.
2013: Alessandra Dicitore; Leo J Hofland; Daniela Mari; Luca Persani; Michele Caraglia; Annamaria Colao; Silvia Zappavigna; Giovanni Vitale
Combined Treatment with PPAR-γ Agonists in Pancreatic Cancer: A Glimmer of Hope for Cancer Therapy?
Current cancer drug targets 2013;13(4):460-71.
2013: Giuseppe Di Lorenzo; Rossella Di Trolio; Paolo A Ascierto; carlo buonerba; Michele Caraglia; Renato De Domenico; Sabino De Placido; Gabriella Gaudioso; Vincenzo Gigantino; Sisto Perdonà; giuseppe quarto; Renato Franco
EGFR mutational status in penile cancer.
Expert opinion on therapeutic targets 2013;17(5):501-5.
2013: Annamaria Spina; Luigi Sapio; Luca Sorvillo; Michele Caraglia; Emilio Chiosi; Francesca Di Maiolo; Antonietta Esposito; Silvio Naviglio
Synergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells.
Oncology reports 2013;29(5):1689-96.
2013: Renato Franco; Amalia Luce; Federica Zito Marino; Alessandro Morabito; Nicola Normanno; Giuseppe Pirozzi; Gaetano Rocco; Pasquale Sperlongano; Paola Stiuso; Gerardo Botti; Michele Caraglia
Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment?
Expert review of anticancer therapy 2013;13(4):407-20.
2013: Michele Caraglia; Sara Castiglioni; Alessandra Dicitore; Monica Marra; Luca Persani; Pasquale Sperlongano; Pierosandro Tagliaferri; Alberto Abbruzzese; Giovanni Vitale
Type I interferons: ancient peptides with still under-discovered anti-cancer properties.
Protein and peptide letters 2013;20(4):412-23.
2013: Michele Caraglia; Vito de Novellis; Giuseppe De Rosa; Catia Giordano; F Guida; Livio Luongo; Sara Lusa; Monica Marra; Francesco Rossi; Giuseppina Salzano; Silvia Zappavigna; Alberto Abbruzzese Saccardi; Sabatino Maione
Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain.
Molecular pharmaceutics 2013;10(3):1111-8.
2013: Teresa Troiani; Silvia Zappavigna; Santolo R Addeo; Fortunato Ciardiello; Erika Martinelli; Paola Stiuso; Michele Caraglia
Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance.
Expert opinion on biological therapy 2013;13(2):241-55.
2013: carlo buonerba; Michele Caraglia; Davide Bosso; Piera Federico; Matteo Ferro; Simona Malgieri; Giovannella Palmieri; Francesco Perri; Mimma Rizzo; Giuseppe Di Lorenzo
Calcitriol: a better option than vitamin D in denosumab-treated patients with kidney failure?
Expert opinion on biological therapy 2013;13(2):149-51.
2013: Domenico Ciliberto; Pierpaolo Correale; Marco Rossi; Cirino Botta; Michele Caraglia; Pierfrancesco Tassone; Pierosandro Tagliaferri
Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomised trials.
European journal of cancer (Oxford, England : 1990) 2013;49(3):593-603.
2013: Anna Tesei; Greta Varchi; Dino Amadori; Chiara Arienti; Michele Caraglia; Gabriella Castoria; Marzia Di Donato; Elisa Gabucci; Andrea Guerrini; Carlo Leonetti; Giulia Paganelli; Sara Pignatta; Manuela Porru; Wainer Zoli
Effect of Small Molecules Modulating Androgen Receptor (SARMs) in Human Prostate Cancer Models.
PloS one 2013;8(5):e62657.
2013: Giuseppe De Rosa; Gabriella Misso; Giuseppina Salzano; Michele Caraglia
Bisphosphonates and cancer: what opportunities from nanotechnology?
Journal of drug delivery 2013;2013():637976.
2013: Francesco Merlino; Ali Munaim Yousif; Michele Caraglia; Salvatore Di Maro; Paolo Grieco
Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures.
Journal of amino acids 2013;2013():979016.
2013: Renato Franco; Angela Lombardi; Gianfranco Nicoletti; Federica Zito Marino; Gerardo Botti; Marina Di Domenico; Michele Caraglia
Current treatment of cutaneous squamous cancer and molecular strategies for its sensitization to new target-based drugs.
Expert opinion on biological therapy 2013;13(1):51-66.
2013: Gabriella Misso; Filippo Ricciardiello; Pierosandro Tagliaferri; Alberto Abbruzzese; Antonio Giordano; Gaia Giuberti; Anna Grimaldi; Angela Lombardi; Michele Caraglia
Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC.
Journal of cellular physiology 2013;228(1):130-41.
2013: Michele Caraglia; Monica Marra; M H Park; E C Wolff; Alberto Abbruzzese
eIF5A isoforms and cancer: two brothers for two functions?
Amino acids 2013;44(1):103-9.
2012: Gabriella Misso; Manuela Porru; Daniele Santini; Antonella Stoppacciaro; Maria Castellano; Federica De Cicco; Carlo Leonetti; Michele Caraglia
Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid.
Cancer biology & therapy 2012;13(14):1491-500.
2012: Maria T Di Martino; Manlio Ferrarini; Umberto Foresta; Annamaria Gullà; Emanuela Leone; Marta Lionetti; Eugenio Morelli; Nikhil C Munshi; Massimo Negrini; Antonino Neri; Maria R Pitari; Marco Rossi; Masood A Shammas; Pierosandro Tagliaferri; Nicola Amodio; Kenneth C Anderson; Maria E Gallo Cantafio; Michele Caraglia; Francesco Conforti; Vera Tomaino; Pierfrancesco Tassone
Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(22):6260-70.
2012: Nicola Amodio; Dina Bellizzi; Michele Caraglia; Patrizia D'Aquila; Maria Teresa Di Martino; Fernanda Fabiani; Antonio Giordano; Anna Maria Gullà; Emanuela Leone; Marzia Leotta; Marta Lionetti; Massimo Negrini; Antonino Neri; Giuseppe Passarino; Pierosandro Tagliaferri; Pierfrancesco Tassone
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma.
Oncotarget 2012;3(10):1246-58.
2012: Daniele Santini; Marianna Silletta; Umberto Vespasiani; Bruno Vincenzi; Raffaele Addeo; Alice Calvieri; Michele Caraglia; Salvatore Del Prete; Liliana Montella; Antonio Picardi; Giuseppe Tonini
Exploring the efficacy and safety of single-agent sorafenib in a cohort of Italian patients with hepatocellular carcinoma.
Expert review of anticancer therapy 2012;12(10):1283-8.
2012: Raffaele Addeo; Marco Carraturo; Gilda Cennamo; Patrizia Iodice; Angela Lombardi; Liliana Montella; Ciro Parlato; Salvatore Del Prete; Paola Russo; Antonio Salzano; Pasquale Sperlongano; Rossella Sperlongano; Bruno Vincenzi; Michele Caraglia
Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases.
Cancer chemotherapy and pharmacology 2012;70(4):603-9.
2012: Giuseppina Liguori; Angela Lombardi; Fabrizio Zanconati; Rosa Giannatiempo; Elvira La Mantia; Anna La Mura; Gabriella Aquino; Gerardo Botti; Monica Cantile; Michele Caraglia; Margherita Cerrone; Maria Pia Curcio; Antonio D'Antonio; Annarosaria De Chiara; Maurizio Di Bonito; Renato Franco
Breast MALT lymphomas: a clinicopathological and cytogenetic study of 9 cases.
Oncology reports 2012;28(4):1211-6.
2012: Gabriella Aquino; Gerardo Botti; Pantaleo Bufo; Michele Caraglia; Valentina Cozza; Giovanni Cuda; Alfredo De Rosa; Gianluca Florio; Renato Franco; Anna Grimaldi; Giuseppina Liguori; Lorenzo Lo Muzio; Francesco Longo; Simona Losito; Marilena Mattoni; Giuseppe Pannone; Angela Santoro; Carolina Sbordone; Rosario Serpico; stefania staibano; Marina Di Domenico
pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: a tissue-microarray study with clinic-pathological correlations.
Cancer biology & therapy 2012;13(11):967-77.
2012: P Tassone; N Amodio; R Burger; Michele Caraglia; M T Di Martino; E Leone; P Neri; Pierosandro Tagliaferri
Mouse models as a translational platform for the development of new therapeutic agents in multiple myeloma.
Current cancer drug targets 2012;12(7):814-22.
2012: Marco Rossi; Pierfrancesco Tassone; Maria Teresa Di Martino; Anna Grimaldi; Marzia Leotta; Gabriella Misso; Eugenio Morelli; Antonietta Rizzo; Michele Caraglia
Molecular targets for the treatment of multiple myeloma.
Current cancer drug targets 2012;12(7):757-67.
2012: Francesca Ungaro; Alberto Abbruzzese; Claudio Arra; Antonio Barbieri; Michele Caraglia; Claudia Conte; Giovanni Maglio; Gabriella Misso; Luisanna Ostacolo; fabiana Quaglia
Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity.
Nanomedicine : nanotechnology, biology, and medicine 2012;8(5):637-46.
2012: Antongiulio Faggiano; Piero Ferolla; D Ferone; Leo J Hofland; V Ramundo; R Severino; P Sperlongano; Alberto Abbruzzese; M O Borghi; Michele Caraglia; S Castiglioni; Annamaria Colao; L Crinò; Alessandra Dicitore; G Vitale
Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study.
Journal of cellular and molecular medicine 2012;16(7):1563-72.
2012: Cirino Botta; Michele Caraglia; Alberto Abbruzzese; Serena Apollinari; Elena Bestoso; Maria Grazia Cusi; Gabriella Misso; Pierpaolo Pastina; Pasquale Sperlongano; Pierosandro Tagliaferri; Pierfrancesco Tassone; Pierpaolo Correale
Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2012;35(5):440-7.
2012: Domenico Ciliberto; Massimo Di Maio; Domenico Flotta; Ubaldo Prati; Laura Roveda; Nicoletta Staropoli; Alberto Abbruzzese; Vito Barbieri; Michele Caraglia; Pierfrancesco Tassone; Pierosandro Tagliaferri
Role of systemic chemotherapy in the management of resected or resectable colorectal liver metastases: a systematic review and meta-analysis of randomized controlled trials.
Oncology reports 2012;27(6):1849-56.
2012: Antonio Barbieri; Sabrina Bimonte; Michele Caraglia; Maria Di Benedetto; Giuseppe Esposito; Antonia Falco; AMERIGO GIUDICE; Giuseppe Palma; Antonella Petrillo; Mario Petrillo; Alessandra Rosati; Paola Stiuso; Alberto Abbruzzese; Claudio Arra
Role of endothelial nitric oxide synthase (eNOS) in chronic stress-promoted tumour growth.
Journal of cellular and molecular medicine 2012;16(4):920-6.
2012: Michele Caraglia; G De Rosa; Monica Lamberti; A Lombardi; G Salzano; Daniele Santini; Pasquale Sperlongano; Alberto Abbruzzese; Raffaele Addeo
Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier.
Current cancer drug targets 2012;12(3):186-96.
2012: Michele Caraglia; Raffaele Addeo
Editorial: target therapy in brain tumours and metastases.
Current cancer drug targets 2012;12(3):185.
2012: Matteo Ferro; Gaia Giuberti; Sisto Perdonà; Stefania Porto; Pasquale Sperlongano; Silvia Zappavigna; Alberto Abbruzzese; Vincenzo Altieri; carlo buonerba; Giuseppe Di Lorenzo; Gaetano Facchini; Michele Caraglia
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms.
Oncology reports 2012;27(2):409-15.
2012: N Amodio; K C Anderson; Michele Caraglia; F Conforti; M T Di Martino; M Ferrarini; U Foresta; Mariateresa Fulciniti; A M Gullà; E Leone; M Leotta; M Lionetti; G Misso; F Morabito; Nikhil C Munshi; A Neri; M R Pitari; M Rossi; Pierosandro Tagliaferri; Valter Agosti; Pierfrancesco Tassone
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1.
Cell death & disease 2012;3():e436.
2012: Monica Lamberti; Monica Marra; Silvio Naviglio; Delia Pesce; Stefania Porto; Nicola Sannolo; Annamaria Spina; Silvia Zappavigna; Daniela Feola; Anna Grimaldi; Michele Caraglia
5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress.
Journal of experimental & clinical cancer research : CR 2012;31():60.
2012: Massimiliano Galdiero; Michele Caraglia
Nanotechnological and biotechnological strategies for drug delivery.
Current drug metabolism 2012;13(1):2-3.
2012: Giuseppe De Rosa; Giuseppina Salzano; Michele Caraglia; Alberto Abbruzzese
Nanotechnologies: a strategy to overcome blood-brain barrier.
Current drug metabolism 2012;13(1):61-9.
2012: Michele Caraglia; Giuseppe De Rosa; Monica Lamberti; Monica Marra; Gabriella Misso; Giuseppina Salzano; Alberto Abbruzzese
Tumour-specific uptake of anti-cancer drugs: the future is here.
Current drug metabolism 2012;13(1):4-21.
2012: M Colombino; Francesco Izzo; A Lombardi; Alberto Abbruzzese; Marina Accardo; Massimo Agresti; G Botti; Michele Caraglia; Ignazio Sordelli; Pasquale Sperlongano; Luciano Tarantino; fabiana tatangelo; G Palmieri
BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy.
Cell death & disease 2012;3():e259.
2012: Giovanni Vitale; Silvia Zappavigna; Alberto Abbruzzese; Giuseppe Arancia; Paola Bendinelli; Alfredo Budillon; Sara Castiglioni; Francesco Cavagnini; Maria Condello; Alessandra Dicitore; Leo J Hofland; Paola Maroni; Monica Marra; Stefania Meschini; Roberta Piccoletti; Peter M Van Koetsveld; Michele Caraglia
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells.
Biotechnology advances 2012;30(1):169-84.
2012: Monica Marra; Manuela Porru; Giuseppina Salzano; Giovanni Vitale; Silvia Zappavigna; Paolo Chieffi; Giuseppe De Rosa; Renato Franco; Maria Immacolata La Rotonda; Monica Lamberti; Carlo Leonetti; Giuseppina Liguori; Alberto Abbruzzese; Gerardo Botti; Michele Caraglia
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study.
Biotechnology advances 2012;30(1):302-9.
2011: Monica Marra; Giuseppina Salzano; Marco Scarsella; Pierosandro Tagliaferri; Pierfrancesco Tassone; Silvia Zappavigna; Alberto Abbruzzese; Roberta Ascani; Teresa Calimeri; Michele Caraglia; Giovanni Cigliana; renato franco; Maria Immacolata La Rotonda; Carlo Leonetti; Giuseppina Liguori; Giuseppe De Rosa
Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes.
Nanomedicine : nanotechnology, biology, and medicine 2011;7(6):955-64.
2011: Maria Teresa Di Martino; Patrizia Doldo; Fernanda Fabiani; Pietro Hiram Guzzi; Emanuela Leone; Maria Saveria Rotundo; Pasquale Sperlongano; Mariamena Arbitrio; Mario Cannataro; Michele Caraglia; Domenico Ciliberto; Danilo Talarico; Pierfrancesco Tassone; Vera Tomaino; Pierosandro Tagliaferri
Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET microarray profiling study.
Cancer biology & therapy 2011;12(9):780-7.
2011: Annalisa Lamberti; Monica Marra; Nunzia Migliaccio; Ferdinando Papale; Augusto Parente; Francesco Rosso; Carmen Sanges; Alberto Abbruzzese; Michele Caraglia; Angela Chambery; Antimo Di Maro; Paolo Arcari
Analysis of interaction partners for eukaryotic translation elongation factor 1A M-domain by functional proteomics.
Biochimie 2011;93(10):1738-46.
2011: Marina Di Domenico; ATTILIO DI SPIEZIO SARDO; Antonia Feola; Mariagrazia Freda; Maurizio Guida; Mirella Iaccarino; Stefania Iaccarino; Simona Losito; Carmine Nappi; Alberto Abbruzzese; Giuseppe Bifulco; Pantaleo Bufo; Michele Caraglia; Gaetano De Rosa; Daniela Pasquali; Carmela Ricciardi; Francesca Sanguedolce; Angela Santoro; Giuseppe Pannone
Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization.
Cancer biology & therapy 2011;12(5):447-57.
2011: Francesca Bruzzese; Michele Caraglia; Carmine Carbone; Elena Di Gennaro; Alessandra Leone; Geny Piro; Monia Rocco; Alfredo Budillon
HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT.
Journal of cellular physiology 2011;226(9):2378-90.
2011: Pierpaolo Correale; Giuseppe Gotti; Monica Lamberti; Antonella Licchetta; Luca Luzzi; Ignazio Martellucci; Gabriella Misso; Marco Pagliuchi; Ornella Romano; Maria Saveria Rotundo; Alberto Abbruzzese; Raffaele Addeo; Serena Apollinari; Assunta Basile; Elena Bestoso; Cirino Botta; Michele Caraglia; Pierosandro Tagliaferri
Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients.
Cancer biology & therapy 2011;12(2):112-8.
2011: Monica Lamberti; Monica Marra; L Marsella; Silvio Naviglio; S Porto; C Ritonnaro; Michele Caraglia; M A Coppola; S Zappavigna; Nicola Sannolo
[Evaluation in vitro of the cardiotoxic effects of 5-fluorouracil for the prevention of cardiovascular damage in health workers occupationally exposed].
Giornale italiano di medicina del lavoro ed ergonomia 2011;33(3 Suppl):298-302.
2011: Raffaele Addeo; Michele Caraglia
Combining temozolomide with other antitumor drugs and target-based agents in the treatment of brain metastases: an unending quest or chasing a chimera?
Expert opinion on investigational drugs 2011;20(7):881-95.
2011: renato franco; Alberto Abbruzzese; Michele Caraglia; Gaetano Facchini; Gerardo Botti
The role of tissue microarray in the era of target-based agents.
Expert review of anticancer therapy 2011;11(6):859-69.
2011: Daniele Santini; Bruno Vincenzi; Vincenzo Adamo; Raffaele Addeo; Vittorio Fusco; Antonio Russo; Filippo Montemurro; Ilaria Roato; Stefania Redana; Gaetano Lanzetta; Maria Antonietta Satolli; Alfredo Berruti; Valentina Leoni; Sara Galluzzo; Mauro Antimi; Giuseppa Ferraro; Maura Rossi; Salvatore Del Prete; Maria Rosaria Valerio; Monica Marra; Michele Caraglia; Giuseppe Tonini
Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients.
Oncology reports 2011;25(6):1545-8.
2011: Raffaele Addeo; Michele Caraglia; M Serena De Santi; Liliana Montella; Alberto Abbruzzese; Ciro Parlato; Bruno Vincenzi; Marco Carraturo; Vincenzo Faiola; Michele Genovese; Gregorio Cennamo; Salvatore Del Prete
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma.
Journal of neuro-oncology 2011;102(3):417-24.
2011: renato franco; Francesca Boscia; Vincenzo Gigantino; Laura Marra; Francesco Esposito; Diana Ferrara; Paolo Pariante; Gerardo Botti; Michele Caraglia; Sergio Minucci; Paolo Chieffi
GPR30 is overexpressed in post-puberal testicular germ cell tumors.
Cancer biology & therapy 2011;11(6):609-13.
2011: Raffaele Addeo; Michele Caraglia
The oral tyrosine kinase inhibitors lapatinib and sunitinib: new opportunities for the treatment of brain metastases from breast cancer?
Expert review of anticancer therapy 2011;11(2):139-42.
2011: Monica Marra; Ignazio Sordelli; Rossella Sperlongano; Paola Stiuso; Luciano Tarantino; Alberto Abbruzzese; Marina Accardo; Massimo Agresti; Michele Caraglia; AMERIGO GIUDICE; Monica Lamberti; Angela Lombardi; Pasquale Sperlongano
Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview.
Journal of translational medicine 2011;9():171.
2011: Massimo Donadelli; I Dando; T Zaniboni; Chiara Costanzo; E Dalla Pozza; Maria Teresa Scupoli; Aldo Scarpa; S Zappavigna; M Marra; A Abbruzzese; M Bifulco; Michele Caraglia; Marta Palmieri
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism.
Cell death & disease 2011;2():e152.
2011: Michele Caraglia; Gaia Giuberti; Monica Marra; Raffaele Addeo; L Montella; M Murolo; Pasquale Sperlongano; Bruno Vincenzi; Silvio Naviglio; S Del Prete; Alberto Abbruzzese; Paola Stiuso
Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR.
Cell death & disease 2011;2():e150.
2011: Paolo Grieco; renato franco; Giuseppina Bozzuto; Laura Toccacieli; Alessandro Sgambato; Monica Marra; Silvia Zappavigna; Mario Migaldi; Giulio Rossi; Stefano Striano; Luigi Marra; Luigi Gallo; Achille Cittadini; Gerardo Botti; Ettore Novellino; Agnese Molinari; Alfredo Budillon; Michele Caraglia
Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells.
Journal of cellular biochemistry 2011;112(1):341-53.
2011: Daniele Santini; Gaia Schiavon; Bruno Vincenzi; Carol E Cass; Enrico Vasile; Andrea D Manazza; Vincenzo Catalano; Giacomo Giulio Baldi; Raymond Lai; Sergio Rizzo; Alice Giacobino; Luigi Chiusa; Michele Caraglia; Antonio Russo; John Mackey; Alfredo Falcone; Giuseppe Tonini
Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC).
Current cancer drug targets 2011;11(1):123-9.
2010: Luisanna Ostacolo; Monica Marra; Francesca Ungaro; Silvia Zappavigna; Giovanni Maglio; fabiana Quaglia; Alberto Abbruzzese; Michele Caraglia
In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role?
Journal of controlled release : official journal of the Controlled Release Society 2010;148(2):255-63.
2010: Liliana Montella; Raffaele Addeo; Michele Caraglia; Salvatore Del Prete
Latest developments in targeted therapy for hepatocellular carcinoma.
Expert review of anticancer therapy 2010;10(10):1635-46.
2010: Salvatore Del Prete; Liliana Montella; Michele Caraglia; Luigi Maiorino; Gilda Cennamo; Vincenzo Montesarchio; Guido Piai; Antonio Febbraro; Luciano Tarantino; Elena Capasso; Giovannella Palmieri; Rosario Guarrasi; Maddalena Bianco; Rosanna Mamone; Clementina Savastano; Agata Pisano; Bruno Vincenzi; Antonietta Sabia; Alberto D'Agostino; Vincenzo Faiola; Raffaele Addeo
Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study.
Cancer chemotherapy and pharmacology 2010;66(5):837-44.
2010: Gaetano Facchini; Michele Caraglia; Alessandro Morabito; Monica Marra; Maria C Piccirillo; Anna M Bochicchio; Stefano Striano; Luigi Marra; Guglielmo Nasti; Ettore Ferrari; Davide Leopardo; Giovanni Vitale; Davide Gentilini; Anna Tortoriello; Alfonso Catalano; Alfredo Budillon; Franco Perrone; Rosario V Iaffaioli
Metronomic administration of zoledronic acid and taxotere combination in castration resistant prostate cancer patients: phase I ZANTE trial.
Cancer biology & therapy 2010;10(6):543-8.
2010: Giovanni Vitale; Letizia M Fatti; Silvia Prolo; Andrea Girola; Michele Caraglia; Monica Marra; Alberto Abbruzzese; Giancarla Gerli; Daniela Mari
Screening for hypothyroidism in older hospitalized patients with anemia: a new insight into an old disease.
Journal of the American Geriatrics Society 2010;58(9):1825-7.
2010: Mara Campioni; Anna Severino; Lucrezia Manente; Ioana L Tuduce; Stefano Toldo; Michele Caraglia; Stefania Crispi; Michael Ehrmann; Xiaoping He; Jacie Maguire; Maria De Falco; Antonio De Luca; Viji Shridhar; Alfonso Baldi
The serine protease HtrA1 specifically interacts and degrades the tuberous sclerosis complex 2 protein.
Molecular cancer research : MCR 2010;8(9):1248-60.
2010: Raffaele Addeo; Alessandro Sgambato; Gilda Cennamo; Liliana Montella; Vincenzo Faiola; Alberto Abbruzzese; Elena Capasso; Luigi Leo; Gerardo Botti; Michele Caraglia; Salvatore Del Prete
Low-dose metronomic oral administration of vinorelbine in the first-line treatment of elderly patients with metastatic breast cancer.
Clinical breast cancer 2010;10(4):301-6.
2010: Paola Stiuso; Gaia Giuberti; Angela Lombardi; Alessandra Dicitore; Vittorio Limongelli; Maria Cartenì; Alberto Abbruzzese; Michele Caraglia
Gamma-glutamyl 16-diaminopropane derivative of vasoactive intestinal peptide: a potent anti-oxidative agent for human epidermoid cancer cells.
Amino acids 2010;39(3):661-70.
2010: Daniele Santini; C Spoto; Fotios Loupakis; Bruno Vincenzi; N Silvestris; C Cremolini; E Canestrari; Graziano Francesco; N Galluccio; L Salvatore; Michele Caraglia; F A Zito; G Colucci; Alfredo Falcone; Giuseppe Tonini; Annamaria Ruzzo
High concordance of BRAF status between primary colorectal tumours and related metastatic sites: implications for clinical practice.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(7):1565.
2010: Pierpaolo Correale; Monica Marra; Cinzia Remondo; Cristina Migali; Gabriella Misso; Felice Paolo Arcuri; Maria Teresa Del Vecchio; Antonietta Carducci; Lucia Loiacono; Pierfrancesco Tassone; Alberto Abbruzzese; Pierosandro Tagliaferri; Michele Caraglia
Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC).
European journal of cancer (Oxford, England : 1990) 2010;46(9):1703-11.
2010: Pierpaolo Correale; Cinzia Remondo; Salvatore Francesco Carbone; Veronica Ricci; Cristina Migali; Ignazio Martellucci; Antonella Licchetta; Raffaele Addeo; Luca Volterrani; Giuseppe Gotti; Maria Saveria Rotundo; Pierfrancesco Tassone; Pasquale Sperlongano; Alberto Abbruzzese; Michele Caraglia; Pierosandro Tagliaferri; Guido Francini
Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients.
Cancer biology & therapy 2010;9(9):685-93.
2010: Aldo Giudice; Michele Caraglia; Monica Marra; Maurizio Montella; Nicola Maurea; Alberto Abbruzzese; Claudio Arra
Circadian rhythms, adrenergic hormones and trafficking of hematopoietic stem cells.
Expert opinion on therapeutic targets 2010;14(5):567-75.
2010: Liliana Montella; Raffaele Addeo; Giovannella Palmieri; Michele Caraglia; Gilda Cennamo; Bruno Vincenzi; Rosario Guarrasi; Rosanna Mamone; Vincenzo Faiola; Nicola Frega; Elena Capasso; Luigi Maiorino; Davide Leopardo; Carmine Pizza; Vincenzo Montesarchio; Salvatore Del Prete
Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series.
Cancer chemotherapy and pharmacology 2010;65(6):1137-43.
2010: Raffaele Addeo; Michele Caraglia; Domenico Cerbone; Nicola Frega; Gaetano Cimmino; Alberto Abbruzzese; Salvatore Del Prete
Panitumumab: a new frontier of target therapy for the treatment of metastatic colorectal cancer.
Expert review of anticancer therapy 2010;10(4):499-505.
2010: renato franco; Monica Cantile; Stefania Scala; Elisabetta Catalano; Margherita Cerrone; Giosuè Scognamiglio; Antonio Pinto; Maria Grazia Chiofalo; Corrado Caracò; Anna Maria Anniciello; Alberto Abbruzzese; Michele Caraglia; Gerardo Botti
Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcome.
Cancer biology & therapy 2010;9(6):423-9.
2010: Raffaele Addeo; Michele Caraglia; Sergio Bellini; Alberto Abbruzzese; Bruno Vincenzi; Liliana Montella; Antonio Miragliuolo; Rosario Guarrasi; Michele Lanna; Gregorio Cennamo; Vincenzo Faiola; Salvatore Del Prete
Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(4):543-8.
2010: Bruno Vincenzi; Daniele Santini; Antonio Russo; Raffaele Addeo; Francesco Giuliani; Liliana Montella; Sergio Rizzo; Olga Venditti; Anna Maria Frezza; Michele Caraglia; Giuseppe Colucci; Salvatore Del Prete; Giuseppe Tonini
Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenib.
The oncologist 2010;15(1):85-92.
2010: Michele Caraglia; Monica Marra; Silvio Naviglio; Gerardo Botti; Raffaele Addeo; Alberto Abbruzzese
Zoledronic acid: an unending tale for an antiresorptive agent.
Expert opinion on pharmacotherapy 2010;11(1):141-54.
2010: Patrizia Gazzerro; Anna Maria Malfitano; Maria Chiara Proto; Antonietta Santoro; Simona Pisanti; Maria Gabriella Caruso; Maria Notarnicola; Caterina Messa; Chiara Laezza; Gabriella Misso; Michele Caraglia; Maurizio Bifulco
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin.
Oncology reports 2010;23(1):171-5.
2009: P Tassone; Pierosandro Tagliaferri; M Rossi; T Calimeri; A Bulotta; Alberto Abbruzzese; Michele Caraglia; P Neri
Challenging the current approaches to multiple myeloma-related bone disease: from bisphosphonates to target therapy.
Current cancer drug targets 2009;9(7):854-70.
2009: D Santini; M E Fratto; Bruno Vincenzi; N Napoli; Sara Galluzzo; M Tantardini; A Abbruzzese; Michele Caraglia; G Tonini
Denosumab: the era of targeted therapies in bone metastatic diseases.
Current cancer drug targets 2009;9(7):834-42.
2009: Monica Marra; Alberto Abbruzzese; Raffaele Addeo; Salvatore Del Prete; P Tassone; G Tonini; Pierosandro Tagliaferri; D Santini; Michele Caraglia
Cutting the limits of aminobisphosphonates: new strategies for the potentiation of their anti-tumour effects.
Current cancer drug targets 2009;9(7):791-800.
2009: Michele Caraglia; Daniele Santini
Target therapy of bone metastases and tumours.
Current cancer drug targets 2009;9(7):789-90.
2009: Gaetano Facchini; Francesco Perri; Michele Caraglia; Carmela Pisano; Stefano Striano; Luigi Marra; Francesco Fiore; Pasquale Aprea; Sandro Pignata; Rosario Vincenzo Iaffaioli
New treatment approaches in renal cell carcinoma.
Anti-cancer drugs 2009;20(10):893-900.
2009: Ivana Sirangelo; Clara Iannuzzi; Silvia Vilasi; Gaetano Irace; Gaia Giuberti; Gabriella Misso; Annamaria D'Alessandro; Alberto Abbruzzese; Michele Caraglia
W7FW14F apomyoglobin amyloid aggregates-mediated apoptosis is due to oxidative stress and AKT inactivation caused by Ras and Rac.
Journal of cellular physiology 2009;221(2):412-23.
2009: Monica Marra; Daniele Santini; Giuseppina Meo; Bruno Vincenzi; Silvia Zappavigna; Alfonso Baldi; Maciej Rosolowski; Giuseppe Tonini; Markus Loeffler; Ruth Lupu; Santolo Rosario Addeo; Alberto Abbruzzese; Alfredo Budillon; Michele Caraglia
Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells.
International journal of cancer. Journal international du cancer 2009;125(9):2004-13.
2009: Raffaele Addeo; Michele Caraglia; Nicola Frega; Salvatore Del Prete
Two faces for Janus: recombinant human erythropoiesis-stimulating agents and cancer mortality.
Expert review of hematology 2009;2(5):513-5.
2009: Raffaele Addeo; M Serena De Santi; Salvatore Del Prete; Michele Caraglia
Fotemustine and recurrent glioblastoma: possible new opportunities for an old drug.
Cancer chemotherapy and pharmacology 2009;64(5):863-6.
2009: Monica Marra; Aldo Giudice; Claudio Arra; Giovanni Vitale; Sara Castiglioni; Guglielmo Nasti; Angela Lombardi; Alessandro Ottaiano; Gaetano Facchini; Rosario V Iaffaioli; Alberto Abbruzzese; Michele Caraglia
Target-based agents in neoadjuvant treatment of liver metastases from colorectal cancer: secret weapons in anti-cancer war?
Cancer biology & therapy 2009;8(18):1709-18.
2009: Michele Caraglia; Monica Marra; Pierosandro Tagliaferri; S W J Lamberts; S Zappavigna; G Misso; Francesco Cavagnini; G Facchini; Alberto Abbruzzese; Leo Hofland; Giovanni Vitale
Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways.
Current cancer drug targets 2009;9(5):690-704.
2009: Francesco Pantano; Alfonso Baldi; Daniele Santini; Bruno Vincenzi; Domenico Borzomati; Fabio Maria Vecchio; Federica Castri; Armando Antinori; Michele Caraglia; Paolo Magistrelli; Roberto Coppola; Giuseppe Tonini
MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients.
Cancer biology & therapy 2009;8(11):996-9.
2009: Giovanni Vitale; Michele Caraglia; Peter M Van Koetsveld; Paola Maroni; Monica Marra; Annamaria Colao; Steven W J Lamberts; Francesco Cavagnini; Leo J Hofland
Potential role of type I interferons in the treatment of pituitary adenomas.
Reviews in endocrine & metabolic disorders 2009;10(2):125-33.
2009: Stefano Fogli; Michele Caraglia
Genotype-based therapeutic approach for colorectal cancer: state of the art and future perspectives.
Expert opinion on pharmacotherapy 2009;10(7):1095-108.
2009: Raffaele Addeo; Michele Caraglia; Salvatore Del Prete
Highlights of the Pananemia National Meeting of the Italian Southern Oncological Group (GOIM): pharmacological and molecular treatment of cancer-induced anemia. Sorrento, Italy, 19-20 December 2008.
Expert opinion on pharmacotherapy 2009;10(6):1089-93.
2009: Pierfrancesco Tassone; Maria Teresa Di Martino; Monica Ventura; Antonella Pietragalla; Iole Cucinotto; Teresa Calimeri; Alessandra Bulotta; Paola Neri; Michele Caraglia; Pierosandro Tagliaferri
Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo.
Cancer biology & therapy 2009;8(7):648-53.
2009: Pierpaolo Correale; Michele Caraglia; Giuseppe Gotti; Paolo Macrì; Cristina Migali; Cinzia Remondo; Maria Saveria Rotundo; Pierosandro Tagliaferri; Salvatora Tindara Miano; Guido Francini
Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetaxel +/- granulocyte-macrophage colony stimulating factor and low dose aldesleukine.
Cancer biology & therapy 2009;8(6):497-502.
2009: Raffaele Addeo; Michele Caraglia; Salvatore Del Prete
Highlights of regional meeting of Italian Southern Oncological Group (GOIM): focus on hepatocellular carcinoma: biological and clinical background, therapeutic guide-lines and perspectives. 7 November 2008, Naples, Italy.
Expert opinion on investigational drugs 2009;18(3):373-8.
2009: Giovanni Vitale; Davide Gentilini; Alberto Abbruzzese; Michele Caraglia
Pyk2 and Cyr61 at the cross-road of cAMP-dependent signalling in invasiveness and neuroendocrine differentiation of prostate cancer.
Cancer biology & therapy 2009;8(3):243-4.
2009: Velia D'Angelo; Stefania Crisci; Fiorina Casale; Raffaele Addeo; Maria Giuliano; Elvira Pota; Paola Finsinger; Alfonso Baldi; Roberto Rondelli; Alberto Abbruzzese; Michele Caraglia; Paolo Indolfi
High Erk-1 activation and Gadd45a expression as prognostic markers in high risk pediatric haemolymphoproliferative diseases.
Journal of experimental & clinical cancer research : CR 2009;28():39.
2009: Silvio Naviglio; Michele Caraglia; Alberto Abbruzzese; Emilio Chiosi; Davide Di Gesto; Monica Marra; Maria Romano; Annunziata Sorrentino; Luca Sorvillo; Annamaria Spina; Gennaro Illiano
Protein kinase A as a biological target in cancer therapy.
Expert opinion on therapeutic targets 2009;13(1):83-92.
2008: Monica Marra; A Lombardi; E Agostinelli; Gaia Giuberti; S Zappavigna; G Tempera; Giovanni Vitale; M Bifulco; Alberto Abbruzzese; Michele Caraglia
Bovine serum amine oxidase and spm potentiate docetaxel and interferon-alpha effects in inducing apoptosis on human cancer cells through the generation of oxidative stress.
Biochimica et biophysica acta 2008;1783(12):2269-78.
2008: Chiara Laezza; Laura Fiorentino; Simona Pisanti; Patrizia Gazzerro; Michele Caraglia; Giuseppe Portella; Mario Vitale; Maurizio Bifulco
Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state.
Journal of molecular medicine (Berlin, Germany) 2008;86(12):1341-51.
2008: Paola Neri; Pierosandro Tagliaferri; Maria Teresa Di Martino; Teresa Calimeri; Nicola Amodio; Alessandra Bulotta; Monica Ventura; Pasqua Orietta Eramo; Caterina Viscomi; Mariamena Arbitrio; Marco Rossi; Michele Caraglia; Nikhil C Munshi; Kenneth C Anderson; Pierfrancesco Tassone
In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
British journal of haematology 2008;143(4):520-31.
2008: Bruno Vincenzi; Giuseppe Patti; Sara Galluzzo; Francesco Pantano; Olga Venditti; Daniele Santini; Annamaria Ruzzo; Gaia Schiavon; Michele Caraglia; Monica Marra; Graziano Francesco; Giuseppe Tonini
Interleukin 1beta-511T gene (IL1beta) polymorphism is correlated with gastric cancer in the Caucasian population: results from a meta-analysis.
Oncology reports 2008;20(5):1213-20.
2008: Raffaele Addeo; Carmine De Rosa; Vincenzo Faiola; Luigi Leo; Gregorio Cennamo; Liliana Montella; Rosario Guarrasi; Bruno Vincenzi; Michele Caraglia; Salvatore Del Prete
Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases.
Cancer 2008;113(9):2524-31.
2008: Marilena Lepretti; Susan Costantini; Gaetano Ammirato; Gaia Giuberti; Michele Caraglia; Angelo M Facchiano; Salvatore Metafora; Paola Stiuso
The N-terminal 1-16 peptide derived in vivo from protein seminal vesicle protein IV modulates alpha-thrombin activity: potential clinical implications.
Experimental & molecular medicine 2008;40(5):541-9.
2008: Michele Caraglia; M Carteni; A Dicitore; D Cassese; salvatore de maria; P Ferranti; G Giuberti; Alberto Abbruzzese; P Stiuso
Experimental study on vasoactive intestinal peptide (VIP) and its diaminopropane bound (VIP-DAP) analog in solution.
Amino acids 2008;35(2):275-81.
2008: Michele Caraglia; Monica Marra; Alfredo Budillon
Highlights of the Annual Meeting of the Italian Association for Cell Cultures (AICC): new drug delivery strategies and technological platforms for diagnosis and therapy of tumors. Part II. 6 - 7 December 2007, Naples, Italy.
Expert opinion on biological therapy 2008;8(7):1031-5.
2008: Raffaele Addeo; Vincenzo Faiola; Rosario Guarrasi; Liliana Montella; Bruno Vincenzi; Elena Capasso; Gregorio Cennamo; Maria Saveria Rotundo; Pierosandro Tagliaferri; Michele Caraglia; Salvatore Del Prete
Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women > or = 65 years of age.
Cancer chemotherapy and pharmacology 2008;62(2):285-92.
2008: Michele Caraglia; Monica Marra; Alfredo Budillon
Highlights of the annual meeting of the Italian Association for Cell Cultures (AICC): new drug delivery strategies and technological platforms for diagnosis and therapy of tumors (Part I) 6 - 7 December 2007, Naples, Italy.
Expert opinion on biological therapy 2008;8(6):845-54.
2008: Marisa Colone; Annarica Calcabrini; Laura Toccacieli; Giuseppina Bozzuto; Annarita Stringaro; Massimo Gentile; Maurizio Cianfriglia; Alessandra Ciervo; Michele Caraglia; Alfredo Budillon; Giuseppina Meo; Giuseppe Arancia; Agnese Molinari
The multidrug transporter P-glycoprotein: a mediator of melanoma invasion?
The Journal of investigative dermatology 2008;128(4):957-71.
2008: Raffaele Addeo; Vincenzo Nocera; Vincenzo Faiola; Bruno Vincenzi; Gabriella Ferraro; Liliana Montella; Rosario Guarrasi; Eugenio Rossi; Gilda Cennamo; Giuseppe Tonini; Elena Capasso; Daniele Santini; Michele Caraglia; Salvatore Del Prete
Management of pain in elderly patients receiving infusion of zoledronic acid for bone metastasis: a single-institution report.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008;16(2):209-14.
2008: Alessandro Lentini; Bruno Provenzano; Michele Caraglia; A Shevchenko; Alberto Abbruzzese; Simone Beninati
Impairment of the metastatic activity of melanoma cells by transglutaminase-catalyzed incorporation of polyamines into laminin and Matrigel.
Amino acids 2008;34(2):251-6.
2007: Michele Caraglia; Monica Marra; Caterina Viscomi; Anna Maria D'Alessandro; Alfredo Budillon; Giuseppina Meo; Claudio Arra; Antonio Barbieri; Ulf R Rapp; Alfonso Baldi; Pierfrancesco Tassone; Salvatore Venuta; Alberto Abbruzzese; Pierosandro Tagliaferri
The farnesyltransferase inhibitor R115777 (ZARNESTRA) enhances the pro-apoptotic activity of interferon-alpha through the inhibition of multiple survival pathways.
International journal of cancer. Journal international du cancer 2007;121(10):2317-30.
2007: Raffaele Addeo; Liliana Montella; Alfonso Baldi; Gregorio Cennamo; Rosario Guarrasi; Vincenzo Faiola; Michele Caraglia; Salvatore Del Prete
Atypical cutaneous lymphoid hyperplasia induced by chemotherapy in a patient with advanced colon carcinoma.
Clinical colorectal cancer 2007;6(10):728-30.
2007: Gaetano Facchini; Michele Caraglia; D Santini; Guglielmo Nasti; Alessandro Ottaiano; S Striano; P Maiolino; M Ruberto; F Fiore; G Tonini; A Budillon; Rosario Vincenzo Iaffaioli; G L Zeppetella
The clinical response on bone metastasis from breast and lung cancer during treatment with zoledronic acid is inversely correlated to skeletal related events (SRE).
Journal of experimental & clinical cancer research : CR 2007;26(3):307-12.
2007: Daniele Santini; Bruno Vincenzi; Sara Galluzzo; Fabrizio Battistoni; Laura Rocci; Olga Venditti; Gaia Schiavon; Silvia Angeletti; Federica Uzzalli; Michele Caraglia; Giordano Dicuonzo; Giuseppe Tonini
Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(15 Pt 1):4482-6.
2007: Monica Marra; Enzo Agostinelli; Gianna Tempera; A Lombardi; Giuseppina Meo; Alfredo Budillon; Alberto Abbruzzese; Gaia Giuberti; Michele Caraglia
Anticancer drugs and hyperthermia enhance cytotoxicity induced by polyamine enzymatic oxidation products.
Amino acids 2007;33(2):273-81.
2007: Antonio Avallone; Elena Di Gennaro; Francesca Bruzzese; Gianluca Laus; Paolo Delrio; Michele Caraglia; Stefano Pepe; Pasquale Comella; Alfredo Budillon
Synergistic antitumour effect of raltitrexed and 5-fluorouracil plus folinic acid combination in human cancer cells.
Anti-cancer drugs 2007;18(7):781-91.
2007: Emilio Chiosi; Annamaria Spina; Angela Sorrentino; Maria Romano; Luca Sorvillo; Giovanna Senatore; Raffaella D'Auria; Alberto Abbruzzese; Michele Caraglia; Silvio Naviglio; Gennaro Illiano
Change in TNF-alpha receptor expression is a relevant event in doxorubicin-induced H9c2 cardiomyocyte cell death.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2007;27(7):589-97.
2007: Massimo Donadelli; Chiara Costanzo; Stefania Beghelli; Maria Teresa Scupoli; Mario Dandrea; Antonio Bonora; Paolo Piacentini; Alfredo Budillon; Michele Caraglia; Aldo Scarpa; Marta Palmieri
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine.
Biochimica et biophysica acta 2007;1773(7):1095-106.
2007: Alfredo Budillon; Elena Di Gennaro; Francesca Bruzzese; Monia Rocco; Giuseppe Manzo; Michele Caraglia
Histone deacetylase inhibitors: a new wave of molecular targeted anticancer agents.
Recent patents on anti-cancer drug discovery 2007;2(2):119-34.
2007: Marco Sagristani; Michele Caraglia; Maria Rosaria Villa; A Lucania; M Esposito; L Petriccione; Salvatore Improta; Monica Marra; G Iannaci; R Rossiello; Lucia Mastrullo
Concomitant occurrence of a primary renal NHL and of a papillary urothelial ureter cancer.
Journal of experimental & clinical cancer research : CR 2007;26(2):291-2.
2007: Guglielmo Nasti; Gaetano Facchini; Michele Caraglia; renato franco; Anna La Mura; Maria Staiano; Alfredo Budillon; Rosario Vincenzo Iaffaioli; Alessandro Ottaiano
Concomitant occurrence of facial cutaneous and parotid gland metastases from rectal cancer after preoperative chemoradiotherapy.
Onkologie 2007;30(6):324-6.
2007: Raffaele Addeo; Stefania Crisci; Velia D'Angelo; Bruno Vincenzi; Fiorina Casale; Guido Pettinato; Vittoria Donofrio; Renata Boldrini; Rita Alaggio; Paola Collini; Roberta Bertorelle; Maria Teresa Di Tullio; Michele Caraglia; Monica Terenziani; Margherita Lo Curto; Paolo Indolfi
Bax mutation and overexpression inversely correlate with immature phenotype and prognosis of childhood germ cell tumors.
Oncology reports 2007;17(5):1155-61.
2007: Annalisa Lamberti; Olimpia Longo; Monica Marra; Pierosandro Tagliaferri; Ettore Bismuto; Antonio Fiengo; Caterina Viscomi; Alfredo Budillon; U R Rapp; E Wang; Salvatore Venuta; Alberto Abbruzzese; Paolo Arcari; Michele Caraglia
C-Raf antagonizes apoptosis induced by IFN-alpha in human lung cancer cells by phosphorylation and increase of the intracellular content of elongation factor 1A.
Cell death and differentiation 2007;14(5):952-62.
2007: Michele Caraglia; Monica Marra; Carlo Leonetti; Giuseppina Meo; Anna Maria D'Alessandro; Alfonso Baldi; Daniele Santini; Giuseppe Tonini; Raffaello Bertieri; Gabriella Zupi; Alfredo Budillon; Alberto Abbruzzese
R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation.
Journal of cellular physiology 2007;211(2):533-43.
2007: Alessandro Lentini; Palma Mattioli; Bruno Provenzano; Alberto Abbruzzese; Michele Caraglia; Simone Beninati
Role of the FAD-dependent polyamine oxidase in the selective formation of N(1),N(8)-bis(gamma-glutamyl)spermidine protein cross-links(1).
Biochemical Society transactions 2007;35(Pt 2):396-400.
2007: A Vetrano; Raffaele Addeo; I Russo; Giuseppina Meo; G De Rosa; F D'Anna; Michele Caraglia
A case of clear renal cell cancer associated to meningioma and verrucous carcinoma of frontal region in an old patient.
Journal of experimental & clinical cancer research : CR 2007;26(1):157-9.
2007: Silvio Naviglio; Annamaria Spina; Monica Marra; Angela Sorrentino; Emilio Chiosi; Marco Romano; Salvatore Improta; Alfredo Budillon; Gennaro Illiano; Alberto Abbruzzese; Michele Caraglia
Adenylate cyclase/cAMP pathway downmodulation counteracts apoptosis induced by IFN-alpha in human epidermoid cancer cells.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2007;27(2):129-36.
2007: Giovannella Palmieri; Liliana Montella; Cinzia Aiello; Federica Barbieri; Dolores Di Vizio; S Schulz; Simone Beninati; Alfredo Budillon; Michele Caraglia; Luigi Insabato; Tullio Florio
Somatostatin analogues, a series of tissue transglutaminase inducers, as a new tool for therapy of mesenchimal tumors of the gastrointestinal tract.
Amino acids 2007;32(3):395-400.
2007: Raffaele Addeo; Michele Caraglia; Vincenzo Faiola; Elena Capasso; Bruno Vincenzi; Liliana Montella; Rosario Guarrasi; Luigi Caserta; Salvatore Del Prete
Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life.
BMC cancer 2007;7():18.
2007: Giovannella Palmieri; Mirella Marino; Marco Salvatore; Alfredo Budillon; Giuseppina Meo; Michele Caraglia; Liliana Montella
Cetuximab is an active treatment of metastatic and chemorefractory thymoma.
Frontiers in bioscience : a journal and virtual library 2007;12():757-61.
2006: Daniele Santini; Gaia Schiavon; Silvia Angeletti; Bruno Vincenzi; Simona Gasparro; Claudia Grilli; Annalisa La Cesa; Vladimir Virzí; Valentina Leoni; Alfredo Budillon; Santolo R Addeo; Michele Caraglia; Giordano Dicuonzo; Giuseppe Tonini
Last generation of amino-bisphosphonates (N-BPs) and cancer angio-genesis: a new role for these drugs?
Recent patents on anti-cancer drug discovery 2006;1(3):383-96.
2006: Fabrizio Mancinelli; Michele Caraglia; Alfredo Budillon; Alberto Abbruzzese; Ettore Bismuto
Molecular dynamics simulation and automated docking of the pro-apoptotic Bax protein and its complex with a peptide designed from the Bax-binding domain of anti-apoptotic Ku70.
Journal of cellular biochemistry 2006;99(1):305-18.
2006: Michele Caraglia; Alessandra Dicitore; Gaia Giuberti; Diana Cassese; Marilena Lepretti; Maria Cartenì; Alberto Abbruzzese; Paola Stiuso
Effects of VIP and VIP-DAP on proliferation and lipid peroxidation metabolism in human KB cells.
Annals of the New York Academy of Sciences 2006;1070():167-72.
2006: Michele Caraglia; Monica Marra; Giuseppina Meo; Santolo R Addeo; Pierosandro Tagliaferri; Alfredo Budillon
EGF-R small inhibitors and anti-EGF-R antibodies: advantages and limits of a new avenue in anticancer therapy.
Recent patents on anti-cancer drug discovery 2006;1(2):209-22.
2006: Daniele Santini; Michele Caraglia; Bruno Vincenzi; Ingunn Holen; Susanna Scarpa; Alfredo Budillon; Giuseppe Tonini
Mechanisms of disease: Preclinical reports of antineoplastic synergistic action of bisphosphonates.
Nature clinical practice. Oncology 2006;3(6):325-38.
2006: Daniele Santini; Bruno Vincenzi; Rosemary A Hannon; Janet E Brown; Giordano Dicuonzo; Silvia Angeletti; Annalisa La Cesa; Robert E Coleman; Giuseppe Tonini; Alfredo Budillon; Michele Caraglia; Ingunn Holen
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours.
Oncology reports 2006;15(5):1351-7.
2006: Michele Caraglia; Daniele Santini; Monica Marra; Bruno Vincenzi; Giuseppe Tonini; Alfredo Budillon
Emerging anti-cancer molecular mechanisms of aminobisphosphonates.
Endocrine-related cancer 2006;13(1):7-26.
2006: Francesca Bruzzese; Elena Di Gennaro; Antonio Avallone; Stefano Pepe; Claudio Arra; Michele Caraglia; Pierosandro Tagliaferri; Alfredo Budillon
Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(2):617-25.
2006: Daniele Santini; Graziano Francesco; Vincenzo Catalano; Marisa Di Seri; Enrica Testa; Anna Maria Baldelli; Paolo Giordani; Annalisa La Cesa; Bruno Spalletta; Bruno Vincenzi; A Russo; Michele Caraglia; V Virzi; Stefano Cascinu; Giuseppe Tonini
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial.
BMC cancer 2006;6():125.
2006: Paolo Magistrelli; Roberto Coppola; Giuseppe Tonini; Bruno Vincenzi; Daniele Santini; Domenico Borzomati; Fabio Maria Vecchio; sergio valeri; Federica Castri; Armando Antinori; Gennaro Nuzzo; Michele Caraglia; Aurelio Picciocchi
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma.
Journal of cellular biochemistry 2006;97(1):98-108.
2006: Michele Caraglia; Raffaele Addeo; Raffaele Costanzo; Liliana Montella; Vincenzo Faiola; Monica Marra; Alberto Abbruzzese; Giovannella Palmieri; Alfredo Budillon; Francesco Grillone; Salvatore Venuta; Pierosandro Tagliaferri; Salvatore Del Prete
Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours.
Cancer chemotherapy and pharmacology 2006;57(1):34-9.
2005: Pierpaolo Correale; Fabio Fulfaro; Stefania Marsili; Giuseppe Cicero; Eugenia Bajardi; Chiara Intrivici; Giuseppe Vuolo; Anton Ferdinando Carli; Michele Caraglia; Salvatore Del Prete; Ettore Greco; Nicola Gebbia; Guido Francini
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer.
Cancer chemotherapy and pharmacology 2005;56(6):563-8.
2005: Michele Caraglia; Simone Beninati; Gaia Giuberti; Anna Maria D'Alessandro; Alessandro Lentini; Alberto Abbruzzese; G Bove; F Landolfi; F Rossi; E Lampa; M Costantino
Alternative therapy of earth elements increases the chondroprotective effects of chondroitin sulfate in mice.
Experimental & molecular medicine 2005;37(5):476-81.
2005: Michele Caraglia; Monica Marra; Alfredo Budillon; Giuseppina Meo; Filippo Ricciardiello; Ettore Bismuto; Giovanni Brachelente; Guido Francini; Antonio Giordano; Pierpaolo Correale; Alberto Abbruzzese
Chemotherapy regimen GOLF induces apoptosis in colon cancer cells through multi-chaperone complex inactivation and increased Raf-1 ubiquitin-dependent degradation.
Cancer biology & therapy 2005;4(10):1159-67.
2005: Michele Caraglia; Monica Marra; Fabrizio Mancinelli; Guglielmo d'Ambrosio; Rita Massa; Antonio Giordano; Alfredo Budillon; Alberto Abbruzzese; Ettore Bismuto
Electromagnetic fields at mobile phone frequency induce apoptosis and inactivation of the multi-chaperone complex in human epidermoid cancer cells.
Journal of cellular physiology 2005;204(2):539-48.
2005: Pierpaolo Correale; Maria Grazia Cusi; Maria Teresa del Vecchio; Angelo Aquino; Salvatore Pasquale Prete; Salvatore Prete; Kwong-Yok Tsang; Lucia Micheli; Cristina Nencini; Marco La Placa; Francesco Montagnani; Chiara Terrosi; Michele Caraglia; Vincenzo Formica; Gianluca Giorgi; Enzo Bonmassar; Guido Francini
Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(2):820-8.
2005: Liliana Montella; Michele Caraglia; Alberto Abbruzzese; Andrea Soricelli; M Caputi; G Squame; Marco Salvatore; Salvatore Del Prete; G Palmieri
Mediastinal images resembling thymus following 131-I treatment for thyroid cancer.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo 2005;63(2):114-7.
2005: Michele Caraglia; Liliana Montella; Raffaele Addeo; Raffaele Costanzo; Vincenzo Faiola; Salvatore Del Prete; Feliciano Baldi; Alfonso Baldi; Alberto Abbruzzese; Marco Alloisio
Conditions suggesting lymphoma: case 2. Mediastinal liposarcoma in a patient with previous testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3844-6.
2005: Rosario Vincenzo Iaffaioli; Roberta Formato; Anna Tortoriello; Salvatore Del Prete; Michele Caraglia; G Pappagallo; Agata Pisano; Vittorio Gebbia; F Fanelli; Giovanni Pietro Ianniello; Silvio Cigolari; C Pizza; O Marano; Giuseppe Pezzella; Tonino Pedicini; Antonio Febbraro; P Incoronato; Luigi Manzione; Ettore Ferrari; Nicola Marzano; Stefano Quattrin; Salvatore Pisconti; Guglielmo Nasti; G Giotta; Giuseppe Colucci
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer.
British journal of cancer 2005;92(9):1621-5.
2005: Alfredo Budillon; Francesca Bruzzese; Elena Di Gennaro; Michele Caraglia
Multiple-target drugs: inhibitors of heat shock protein 90 and of histone deacetylase.
Current drug targets 2005;6(3):337-51.
2005: Michele Caraglia; Alfredo Budillon; Pierosandro Tagliaferri; Monica Marra; Alberto Abbruzzese; Francesco Caponigro
Isoprenylation of intracellular proteins as a new target for the therapy of human neoplasms: preclinical and clinical implications.
Current drug targets 2005;6(3):301-23.
2005: Pierosandro Tagliaferri; Pierfrancesco Tassone; Simona Blotta; Caterina Viscomi; F Grillone; Alfredo Budillon; Michele Caraglia; Salvatore Venuta
Antitumor therapeutic strategies based on the targeting of epidermal growth factor-induced survival pathways.
Current drug targets 2005;6(3):289-300.
2005: Francesco Caponigro; Roberta Formato; Michele Caraglia; Nicola Normanno; Rosario Vincenzo Iaffaioli
Monoclonal antibodies targeting epidermal growth factor receptor and vascular endothelial growth factor with a focus on head and neck tumors.
Current opinion in oncology 2005;17(3):212-7.
2005: Loredana Postiglione; Gilda Di Domenico; Michele Caraglia; Monica Marra; Gaia Giuberti; L Del Vecchio; Stefania Montagnani; M Macri; Eugenia Maria Bruno; Alberto Abbruzzese; Guido Rossi
Differential expression and cytoplasm/membrane distribution of endoglin (CD105) in human tumour cell lines: Implications in the modulation of cell proliferation.
International journal of oncology 2005;26(5):1193-201.
2005: Girolamo Pelaia; Giovanni Cuda; Alessandro Vatrella; Luca Gallelli; Michele Caraglia; Monica Marra; Alberto Abbruzzese; Mario Caputi; Rosario Maselli; Francesco Costanzo; Serafino A Marsico
Mitogen-activated protein kinases and asthma.
Journal of cellular physiology 2005;202(3):642-53.
2005: Liliana Montella; Michele Caraglia; Raffaele Addeo; Raffaele Costanzo; Vincenzo Faiola; Alberto Abbruzzese; Salvatore Del Prete
Atrial fibrillation following chemotherapy for stage IIIE diffuse large B-cell gastric lymphoma in a patient with myotonic dystrophy (Steinert's disease).
Annals of hematology 2005;84(3):192-3.
2005: Michele Caraglia; Monica Marra; Girolamo Pelaia; Rosario Maselli; Mario Caputi; Serafino A Marsico; Alberto Abbruzzese
Alpha-interferon and its effects on signal transduction pathways.
Journal of cellular physiology 2005;202(2):323-35.
2005: Michele Caraglia; Gaia Giuberti; Monica Marra; Elena Di Gennaro; Gaetano Facchini; Francesco Caponigro; Rosario Vincenzo Iaffaioli; Alfredo Budillon; Alberto Abbruzzese
Docetaxel induces p53-dependent apoptosis and synergizes with farnesyl transferase inhibitor r115777 in human epithelial cancer cells.
Frontiers in bioscience : a journal and virtual library 2005;10():2566-75.
2005: Pierosandro Tagliaferri; Michele Caraglia; Alfredo Budillon; Monica Marra; Giovanni Vitale; Caterina Viscomi; Serena Masciari; Pierfrancesco Tassone; Alberto Abbruzzese; Salvatore Venuta
New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-alpha) treatment of human cancer.
Cancer immunology, immunotherapy : CII 2005;54(1):1-10.
2005: Raffaele Addeo; Michele Caraglia; Alfonso Baldi; Velia D'Angelo; Fiorina Casale; Stefania Crisci; Alberto Abbruzzese; Bruno Vincenze; Mara Campioni; Maria Teresa Di Tullio; Paolo Indolfi
Prognostic role of bcl-xL and p53 in childhood acute lymphoblastic leukemia (ALL).
Cancer biology & therapy 2005;4(1):32-8.
2004: Michele Caraglia; Giovanni Vitale; Monica Marra; Alfredo Budillon; Pierosandro Tagliaferri; Alberto Abbruzzese
Alpha-interferon and its effects on signalling pathways within cells.
Current protein & peptide science 2004;5(6):475-85.
2004: Fiorina Casale; Velia D'Angelo; Raffaele Addeo; Michele Caraglia; Stefania Crisci; Roberto Rondelli; Maria Teresa Di Tullio; Paolo Indolfi
P-glycoprotein 170 expression and function as an adverse independent prognostic factor in childhood acute lymphoblastic leukemia.
Oncology reports 2004;12(6):1201-7.
2004: Mariarosaria Boccellino; Gaia Giuberti; Lucio Quagliuolo; Monica Marra; Anna Maria D'Alessandro; H Fujita; Alfonso Giovane; Alberto Abbruzzese; Michele Caraglia
Apoptosis induced by interferon-alpha and antagonized by EGF is regulated by caspase-3-mediated cleavage of gelsolin in human epidermoid cancer cells.
Journal of cellular physiology 2004;201(1):71-83.
2004: Michele Caraglia; Anna Maria D'Alessandro; Monica Marra; Gaia Giuberti; Giovanni Vitale; Caterina Viscomi; Annamaria Colao; Salvatore Del Prete; Pierosandro Tagliaferri; Pierfrancesco Tassone; Alfredo Budillon; Salvatore Venuta; Alberto Abbruzzese
The farnesyl transferase inhibitor R115777 (Zarnestra) synergistically enhances growth inhibition and apoptosis induced on epidermoid cancer cells by Zoledronic acid (Zometa) and Pamidronate.
Oncogene 2004;23(41):6900-13.
2004: Fabrizio Mancinelli; Michele Caraglia; Alberto Abbruzzese; Guglielmo d'Ambrosio; Rita Massa; Ettore Bismuto
Non-thermal effects of electromagnetic fields at mobile phone frequency on the refolding of an intracellular protein: myoglobin.
Journal of cellular biochemistry 2004;93(1):188-96.
2004: Annalisa Lamberti; Michele Caraglia; Olimpia Longo; Monica Marra; Alberto Abbruzzese; Paolo Arcari
The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis: review article.
Amino acids 2004;26(4):443-8.
2004: Elena Di Gennaro; Francesca Bruzzese; Michele Caraglia; A Abruzzese; Alfredo Budillon
Acetylation of proteins as novel target for antitumor therapy: review article.
Amino acids 2004;26(4):435-41.
2004: Michele Caraglia; Giovanni Vitale; Monica Marra; Salvatore Del Prete; Alessandro Lentini; Alfredo Budillon; Simone Beninati; Alberto Abbruzzese
Translational and post-translational modifications of proteins as a new mechanism of action of alpha-interferon: review article.
Amino acids 2004;26(4):409-17.
2004: Alessandro Lentini; Alberto Abbruzzese; Michele Caraglia; Monica Marra; Simone Beninati
Protein-polyamine conjugation by transglutaminase in cancer cell differentiation: review article.
Amino acids 2004;26(4):331-7.
2004: Raffaele Addeo; Michele Caraglia; Raffaele Costanzo; Vincenzo Faiola; Liliana Montella; Alberto Abbruzzese; Salvatore Del Prete
Oxaliplatin/rituximab combination in the treatment of intermediate-low grade non-Hodgkin's lymphoma of elderly patients.
Oncology reports 2004;12(1):135-40.
2004: Liliana Montella; Michele Caraglia; Alberto Abbruzzese; Andrea Soricelli; Salvatore Del Prete; Giovanni Squame; Marco Salvatore
Molecular technology and the recombinant TSH have changed diagnostics of thyroid carcinoma with positive I-131 whole body scan but low serum thyroglobulin.
Experimental & molecular medicine 2004;36(3):268-73.
2004: Pierpaolo Correale; Simona Messinese; Michele Caraglia; Stefania Marsili; Alessandro Piccolomini; Roberto Petrioli; Federica Ceciarini; Lucia Micheli; Cristina Nencini; Alessandro Neri; Giuseppe Vuolo; Alfredo Guarnieri; Alberto Abbruzzese; Salvatore Del Prete; Gianluca Giorgi; Guido Francini
A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma.
British journal of cancer 2004;90(9):1710-4.
2004: Raffaele Addeo; Fiorina Casale; Michele Caraglia; Velia D'Angelo; Stefania Crisci; Alberto Abbruzzese; Maria Teresa Di Tullio; Paolo Indolfi
Glucocorticoids induce G1 arrest of lymphoblastic cells through retinoblastoma protein Rb1 dephosphorylation in childhood acute lymphoblastic leukemia in vivo.
Cancer biology & therapy 2004;3(5):470-6.
2003: Pierfrancesco Tassone; Pierosandro Tagliaferri; Caterina Viscomi; Camillo Palmieri; Michele Caraglia; A D'Alessandro; Eulalia Galea; A Goel; Alberto Abbruzzese; C R Boland; Salvatore Venuta
Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro.
British journal of cancer 2003;88(12):1971-8.
2003: Michele Caraglia; Monica Marra; Gaia Giuberti; Anna Maria D'Alessandro; A Baldi; Pierfrancesco Tassone; Salvatore Venuta; Pierosandro Tagliaferri; Alberto Abbruzzese
The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cells.
Journal of biochemistry 2003;133(6):757-65.
2003: Elena Di Gennaro; Marcella Barbarino; Francesca Bruzzese; Sonya De Lorenzo; Michele Caraglia; Alberto Abbruzzese; Antonio Avallone; Pasquale Comella; Francesco Caponigro; Stefano Pepe; Alfredo Budillon
Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.
Journal of cellular physiology 2003;195(1):139-50.
2003: Carla Esposito; Monica Marra; Gaia Giuberti; Anna Maria D'Alessandro; Raffaele Porta; Anna Cozzolino; Michele Caraglia; Alberto Abbruzzese
Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells.
The Biochemical journal 2003;370(Pt 1):205-12.
2003: Michele Caraglia; Pierosandro Tagliaferri; Monica Marra; Gaia Giuberti; Alfredo Budillon; E Di Gennaro; Stefano Pepe; Giovanni Vitale; Salvatore Improta; Pierfrancesco Tassone; Salvatore Venuta; Angelo Raffaele Bianco; Alberto Abbruzzese
EGF activates an inducible survival response via the RAS-> Erk-1/2 pathway to counteract interferon-alpha-mediated apoptosis in epidermoid cancer cells.
Cell death and differentiation 2003;10(2):218-29.
2002: Giovanni Vitale; Antonio Ciccarelli; Michele Caraglia; Maurizio Galderisi; Riccardo Rossi; Salvatore Del Prete; Alberto Abbruzzese; Giovanni Lupoli
Comparison of two provocative tests for calcitonin in medullary thyroid carcinoma: omeprazole vs pentagastrin.
Clinical chemistry 2002;48(9):1505-10.
2002: Michele Caraglia; Monica Marra; Gaia Giuberti; Anna Maria D'Alessandro; Simone Beninati; Alessandro Lentini; Stefano Pepe; Mariarosaria Boccellino; Alberto Abbruzzese
Theophylline-induced apoptosis is paralleled by protein kinase A-dependent tissue transglutaminase activation in cancer cells.
Journal of biochemistry 2002;132(1):45-52.
2002: Claudia Pizzi; Michele Caraglia; Maria Cianciulli; Antonietta Fabbrocini; Anna Libroia; Elide Matano; Alma Contegiacomo; Salvatore Del Prete; Alberto Abbruzzese; Angelo Martignetti; Pierosandro Tagliaferri; Angelo Raffaele Bianco
Low-dose recombinant IL-2 induces psychological changes: monitoring by Minnesota Multiphasic Personality Inventory (MMPI).
Anticancer research 2002;22(2A):727-32.
2001: Angelo M Facchiano; Paola Stiuso; ML Chiusano; Michele Caraglia; Gaia Giuberti; Monica Marra; Alberto Abbruzzese; Giovanni Colonna
Homology modelling of the human eukaryotic initiation factor 5A (eIF-5A).
Protein engineering 2001;14(11):881-90.
2001: Giovanni Vitale; Francesco Fonderico; Angelo Martignetti; Michele Caraglia; Antonio Ciccarelli; Vincenzo Nuzzo; Alberto Abbruzzese; Giovanni Lupoli
Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer.
British journal of cancer 2001;84(12):1586-90.
2001: Giovanni Vitale; Michele Caraglia; Antonio Ciccarelli; Giovanni Lupoli; Alberto Abbruzzese; Pierosandro Tagliaferri; G Lupoli
Current approaches and perspectives in the therapy of medullary thyroid carcinoma.
Cancer 2001;91(9):1797-808.
2001: Michele Caraglia; Monica Marra; Gaia Giuberti; Anna Maria D'Alessandro; Alfredo Budillon; Salvatore Del Prete; Alessandro Lentini; Simone Beninati; Alberto Abbruzzese
The role of eukaryotic initiation factor 5A in the control of cell proliferation and apoptosis.
Amino acids 2001;20(2):91-104.
2000: Alessandro Lentini; F Vidal-Vanaclocha; francesco facchiano; Michele Caraglia; Alberto Abbruzzese; Simone Beninati
Theophylline administration markedly reduces hepatic and pulmonary implantation of B16-F10 melanoma cells in mice.
Melanoma research 2000;10(5):435-43.
2000: Alessandro Lentini; F Autuori; Palma Mattioli; Michele Caraglia; Alberto Abbruzzese; Simone Beninati
Evaluation of the efficacy of potential antineoplastic drugs on tumour metastasis by a computer-assisted image analysis.
European journal of cancer (Oxford, England : 1990) 2000;36(12):1572-7.
2000: Michele Caraglia; Alfredo Budillon; Giovanni Vitale; Giovanni Lupoli; Pierosandro Tagliaferri; Alberto Abbruzzese
Modulation of molecular mechanisms involved in protein synthesis machinery as a new tool for the control of cell proliferation.
European journal of biochemistry / FEBS 2000;267(13):3919-36.
2000: Giovanni Vitale; Pierosandro Tagliaferri; Michele Caraglia; E Rampone; Antonio Ciccarelli; Angelo Raffaele Bianco; Alberto Abbruzzese; Giovanni Lupoli
Slow release lanreotide in combination with interferon-alpha2b in the treatment of symptomatic advanced medullary thyroid carcinoma.
The Journal of clinical endocrinology and metabolism 2000;85(3):983-8.
1999: Alfredo Budillon; Elena Di Gennaro; Michele Caraglia; D Barbarulo; Alberto Abbruzzese; Pierosandro Tagliaferri
8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor.
British journal of cancer 1999;81(7):1134-41.
1999: Michele Caraglia; Alberto Abbruzzese; AI Leardi; Stefano Pepe; Alfredo Budillon; G Baldassare; Carmine Selleri; S D Lorenzo; Antonietta Fabbrocini; Gaia Giuberti; Giovanni Vitale; Giovanni Lupoli; Angelo Raffaele Bianco; Pierosandro Tagliaferri
Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor.
Cell death and differentiation 1999;6(8):773-80.
1999: Michele Caraglia; Elena Di Gennaro; D Barbarulo; Monica Marra; Pierosandro Tagliaferri; Alberto Abbruzzese; Alfredo Budillon
Up-regulated EGF receptors undergo to rapid internalization and ubiquitin-dependent degradation in human cancer cells exposed to 8-Cl-cAMP.
FEBS letters 1999;447(2-3):203-8.
1999: Michele Caraglia; Pierosandro Tagliaferri; Alfredo Budillon; Alberto Abbruzzese
Post-translational modifications of eukaryotic initiation factor-5A (eIF-5A) as a new target for anti-cancer therapy.
Advances in experimental medicine and biology 1999;472():187-98.
1999: Paola Stiuso; Giovanni Colonna; Raffaele Ragone; Michele Caraglia; J W Hershey; Simone Beninati; Alberto Abbruzzese
Structural organization of the human eukaryotic initiation factor 5A precursor and its site-directed variant Lys50-->Arg.
Amino acids 1999;16(1):91-106.
1998: Simone Beninati; Vittorio Gentile; Michele Caraglia; Alessandro Lentini; Pierosandro Tagliaferri; Alberto Abbruzzese
Tissue transglutaminase expression affects hypusine metabolism in BALB/c 3T3 cells.
FEBS letters 1998;437(1-2):34-8.
1998: AI Leardi; Michele Caraglia; Carmine Selleri; Stefano Pepe; Claudia Pizzi; Rosario Notaro; Antonietta Fabbrocini; Sonya De Lorenzo; M Musicò; Alberto Abbruzzese; Angelo Raffaele Bianco; Pierosandro Tagliaferri
Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells.
British journal of haematology 1998;102(3):746-52.
1998: Pierosandro Tagliaferri; Rosario Guarrasi; Michele Caraglia; Daniele Morelli; Antonietta Fabbrocini; P Correale; Angelo Raffaele Bianco
Tumour cell resistance to non-MHC-restricted lymphocytes: molecular mechanisms and clinical implications.
Cancer immunology, immunotherapy : CII 1998;46(3):121-7.
1998: Pierosandro Tagliaferri; C Barile; Michele Caraglia; Rosario Guarrasi; Daniele Morelli; B Ricciardi; Angelo Martignetti; M T Librera; Elide Matano; A Della Vecchia; Giuseppe Catalano; M Famiani; Giovannella Palmieri; P Correale; Angelo Raffaele Bianco
Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effects.
American journal of clinical oncology 1998;21(1):48-53.
1997: Michele Caraglia; AI Leardi; Salvatore Improta; V Perin; B Ricciardi; Claudio Arra; P Ferraro; Antonietta Fabbrocini; Antonio Pinto; Angelo Raffaele Bianco; Pierosandro Tagliaferri
Transient exposure to cytarabine increases peptide growth factor receptor expression and tumorigenicity of melanoma cells.
Anticancer research 1997;17(4A):2369-75.
1997: Michele Caraglia; A Passeggio; Simone Beninati; AI Leardi; L Nicolini; Salvatore Improta; Antonio Pinto; Angelo Raffaele Bianco; Pierosandro Tagliaferri; Alberto Abbruzzese
Interferon alpha2 recombinant and epidermal growth factor modulate proliferation and hypusine synthesis in human epidermoid cancer KB cells.
The Biochemical journal 1997;324 ( Pt 3)():737-41.
1997: P Correale; Pierosandro Tagliaferri; Rosario Guarrasi; Michele Caraglia; Mariateresa Giuliano; M R Marinetti; Angelo Raffaele Bianco; antonio domenico procopio
Extracellular adenosine 5' triphosphate involvement in the death of LAK-engaged human tumor cells via P2X-receptor activation.
Immunology letters 1997;55(2):69-78.
1996: Pierosandro Tagliaferri; P Correale; M Mottola; G de Simone; V Montesarchio; Elide Matano; A Rea; A Morabito; M Famiani; F Ciardiello; G Tortora; Michele Caraglia; C Barile; Giovannella Palmieri; Angelo Raffaele Bianco
High-dose recombinant interleukin-2/verapamil combination in advanced cancer.
European journal of cancer (Oxford, England : 1990) 1996;32A(8):1436-7.
1996: Pierosandro Tagliaferri; Giampaolo Tortora; Rosario Guarrasi; Vincenzo Damiano; A Ruggiero; D Morelli; Michele Caraglia; Roberto Bianco; G di Isernia; Stefano Pepe; Carlos L Arteaga; B C Langton-Webster; Angelo Raffaele Bianco; Fortunato Ciardiello
Differential sensitivity to non-major histocompatibility complex-restricted recombinant interleukin 2-activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or protein kinase A subunits.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(1):207-14.
1995: Michele Caraglia; AI Leardi; S Corradino; Fortunato Ciardiello; Alfredo Budillon; Rosario Guarrasi; Angelo Raffaele Bianco; Pierosandro Tagliaferri
alpha-Interferon potentiates epidermal growth factor receptor-mediated effects on human epidermoid carcinoma KB cells.
International journal of cancer. Journal international du cancer 1995;61(3):342-7.
1995: P Correale; Michele Caraglia; Antonietta Fabbrocini; Rosario Guarrasi; Stefano Pepe; V Patella; Gianni Marone; Antonio Pinto; Angelo Raffaele Bianco; Pierosandro Tagliaferri
Bryostatin 1 enhances lymphokine activated killer sensitivity and modulates the beta 1 integrin profile of cultured human tumor cells.
Anti-cancer drugs 1995;6(2):285-90.
1995: Fortunato Ciardiello; Vincenzo Damiano; C Bianco; G di Isernia; A Ruggiero; Michele Caraglia; Pierosandro Tagliaferri; J Baselga; J Mendelsohn; Angelo Raffaele Bianco
Cooperative antiproliferative effects of 8-chloro-cyclic AMP and 528 anti-epidermal growth factor receptor monoclonal antibody on human cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(2):161-7.
1994: Giovannella Palmieri; A Morabito; A Rea; Michele Caraglia; Pierosandro Tagliaferri; Angelo Raffaele Bianco
Cytosine arabinoside (Ara-C) plus alpha-interferon (alpha IFN) determine prolonged complete remissions in patients with aggressive non-Hodgkin's lymphoma partially responsive to first-line doxorubicin-containing regimens.
British journal of haematology 1994;88(2):421-3.
1994: Michele Caraglia; A M Libroia; S Corradino; V Coppola; Rosario Guarrasi; C Barile; G Genua; Angelo Raffaele Bianco; Pierosandro Tagliaferri
Alpha-interferon induces depletion of intracellular iron content and upregulation of functional transferrin receptors on human epidermoid cancer KB cells.
Biochemical and biophysical research communications 1994;203(1):281-8.
1994: Pierosandro Tagliaferri; Michele Caraglia; Raffaella Muraro; Antonio Pinto; Alfredo Budillon; Vittorina Zagonel; Angelo Raffaele Bianco
Pharmacological modulation of peptide growth factor receptor expression on tumor cells as a basis for cancer therapy.
Anti-cancer drugs 1994;5(4):379-93.
1994: Michele Caraglia; Antonio Pinto; P Correale; Vittorina Zagonel; G Genua; AI Leardi; Stefano Pepe; Angelo Raffaele Bianco; Pierosandro Tagliaferri
5-Aza-2'-deoxycytidine induces growth inhibition and upregulation of epidermal growth factor receptor on human epithelial cancer cells.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(3):269-76.
1993: Michele Caraglia; Pierosandro Tagliaferri; P Correale; G Genua; Antonio Pinto; S Del Vecchio; G Esposito; Angelo Raffaele Bianco
Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb.
Cancer immunology, immunotherapy : CII 1993;37(3):150-6.
1993: P Correale; Pierosandro Tagliaferri; Andrea Camera; Michele Caraglia; Luigi Del Vecchio; M De Laurentis; Antonio Pinto; Bruno Rotoli; Angelo Raffaele Bianco
CD10/common acute lymphoblastic leukemia-associated antigen and adhesion factor expression is predictive for lymphokine-activated killing sensitivity of adult B-lineage acute lymphoblastic leukemia.
The Year in immunology 1993;7():90-5.
1992: P Correale; antonio procopio; L Celio; Michele Caraglia; G Genua; V Coppola; Stefano Pepe; Nicola Normanno; I Vecchio; Giovannella Palmieri
Phorbol 12-myristate 13-acetate induces resistance of human melanoma cells to natural-killer- and lymphokine-activated-killer-mediated cytotoxicity.
Cancer immunology, immunotherapy : CII 1992;34(4):272-8.
1991: Alfredo Budillon; Pierosandro Tagliaferri; Michele Caraglia; M R Torrisi; Nicola Normanno; S Iacobelli; G Palmieri; M P Stoppelli; Luigi Frati; Angelo Raffaele Bianco
Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells.
Cancer research 1991;51(4):1294-9.